Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China

Overview of attention for article published in Frontiers in Public Health, November 2020

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,406 followers.

RT @FrontPubHealth: New Research: Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated Wit…

02 Dec 2020

Reply Repost Favourite

New Research: Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China: Objectives: To access the cost of illness, quality of life and work limitation in… https://t.co/QIlihR3c6g #Public

02 Dec 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.